Table 1.
Patient characteristics of SARS-CoV-2 infected patients. Baseline and at third visit (T3, in median 6•8 months after initial symptoms (T0)). IQR, interquartile range; IgG, immunoglobulin class G.
| Male (n = 445) | Female (n = 513) | Total (n = 958) | ||
|---|---|---|---|---|
| Median age (IQR) | 46 (32–55) | 43 (30–53) | 43 (31–54) | |
| Hospitalisation | 16 (3•6%) | 12 (2•3%) | 28 (2•9%) | |
| Intensive care unit (ICU) | 4 (0•9%) | 3 (0•6%) | 7 (0•7%) | |
| General ward | 12 (2•7%) | 9 (1•8%) | 21 (2•2%) | |
| Preconditions | 105 (23•6%) | 122 (23•7%) | 227 (23•7%) | |
| Hypertension | 46 (10•3%) | 31 (6•0%) | 77 (8.0%) | |
| Chronic lung disease | 11 (2•5%) | 15 (2•9%) | 26 (2•7%) | |
| Malignancies | 8 (1•8%) | 15 (2•9%) | 23 (2•4%) | |
| Autoimmune disease | 4 (0•9%) | 13 (2•5%) | 17 (1•8%) | |
| Diabetes | 7 (1•6%) | 9 (1•8%) | 16 (1•7%) |